Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Cancers|June 2, 2021
Response and Toxicity to the Second Course of 3 Cycles of 177Lu-PSMA Therapy Every 4 Weeks in Patients with Metastatic Castration-Resistant Prostate CancerSazan Rasul, Tim Wollenweber, Lucia Zisser, et al.
Frontiers in Oncology|October 28, 2022
Automated data preparation for in vivo tumor characterization with machine learningDenis Krajnc, Clemens P Spielvogel, Marko Grahovac, et al.
Nuclear Medicine Communications|September 19, 2022
Response to [ 177 Lu]Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer patients presenting with only lymph node metastasesLucia Zisser, Josef Yu, André Oszwald, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 30, 2026
Active Brown Adipose Tissue Is Associated With Reduced Arterial Inflammation and Less Atherogenic Circulating Factors in Individuals With ObesityOana C Kulterer, Carsten T Herz, Dietmar Pils, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 22, 2017
[68Ga]Pentixafor-PET/MRI for the detection of Chemokine receptor 4 expression in atherosclerotic plaquesXiang Li, Daniel Heber, Tatjana Leike, et al.
Molecular and Cellular Endocrinology|July 31, 2021
Characterization of endogenous bile acid composition in individuals with cold-activated brown adipose tissueCarsten T Herz, Oana C Kulterer, Marlene Prager, et al.
Endocrinology|April 4, 2020
Cold Exposure Distinctively Modulates Parathyroid and Thyroid Hormones in Cold-Acclimatized and Non-Acclimatized HumansZuzana Kovaničová, Tímea Kurdiová, Miroslav Baláž, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 21, 2018
Response assessment using 68Ga-PSMA ligand PET in patients undergoing 177Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancerBernhard Grubmüller, Daniela Senn, Gero Kramer, et al.
Current Oncology (Toronto, Ont.)|September 30, 2021
Renal and Salivary Gland Functions after Three Cycles of PSMA-617 Therapy Every Four Weeks in Patients with Metastatic Castration-Resistant Prostate CancerTim Wollenweber, Lucia Zisser, Elisabeth Kretschmer-Chott, et al.
Neuro-Oncology|October 11, 2017
Visual and semiquantitative 11C-methionine PET: an independent prognostic factor for survival of newly diagnosed and treatment-naïve gliomasNina Poetsch, Adelheid Woehrer, Johanna Gesperger, et al.
Pageof 9